TimesSquare Capital Management LLC Has $142.88 Million Stock Holdings in Cencora, Inc. $COR

TimesSquare Capital Management LLC lowered its holdings in Cencora, Inc. (NYSE:COR) by 4.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 423,026 shares of the company’s stock after selling 20,575 shares during the period. Cencora makes up about 2.2% of TimesSquare Capital Management LLC’s portfolio, making the stock its 3rd largest holding. TimesSquare Capital Management LLC owned approximately 0.22% of Cencora worth $142,877,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Vestcor Inc boosted its holdings in Cencora by 0.5% in the 3rd quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after purchasing an additional 28 shares during the period. JFS Wealth Advisors LLC boosted its holdings in Cencora by 30.2% in the 4th quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after purchasing an additional 29 shares during the period. Cornerstone Wealth Group LLC boosted its holdings in Cencora by 1.3% in the 3rd quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock valued at $745,000 after purchasing an additional 30 shares during the period. Apollon Wealth Management LLC boosted its holdings in Cencora by 0.5% in the 4th quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after purchasing an additional 30 shares during the period. Finally, Vermillion & White Wealth Management Group LLC boosted its holdings in Cencora by 31.4% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $43,000 after purchasing an additional 33 shares during the period. Institutional investors own 97.52% of the company’s stock.

Analysts Set New Price Targets

COR has been the subject of several analyst reports. Evercore set a $360.00 target price on shares of Cencora in a research report on Wednesday, April 8th. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Wells Fargo & Company dropped their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research report on Monday, May 11th. William Blair initiated coverage on shares of Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating for the company. Finally, Barclays boosted their target price on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $380.25.

Cencora Price Performance

Shares of NYSE:COR opened at $262.15 on Tuesday. The firm has a 50 day moving average of $312.71 and a 200-day moving average of $338.72. The stock has a market capitalization of $51.00 billion, a PE ratio of 20.10, a PEG ratio of 1.19 and a beta of 0.64. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.Cencora’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities research analysts predict that Cencora, Inc. will post 17.76 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.